Bortezomib in Intrahepatic Cholangiocellular Carcinoma
Clinical trial NCT03345303 · UNKNOWN
Trial details
- NCT number
- NCT03345303
- Sponsor
- Zhengang Yuan
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.